IRCT20200510047383N1招募中3 期
Evaluation of the effect of Tocilizumab on outcomes of the severe COVID-19, determining indications within the paradigm of host-directed therapy
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •COVID-19 disease confirmed by chest ct and PCR
- •No pregnancy
- •No breastfeeding
- •Negative PPD
- •No bacterial pneumonia (negative sputum and urine culture)
- •Not use of atorvastatin , alprazolam , amlodipine , MTX , hydroxychloroquine ,
- •Informed consent
排除标准
- •Disapproval of covid-19 disease by chest computed tomography and PCR
- •Positive PPD
- •Bacterial pneumonia (negative sputum and urine culture)
- •Breastfeeding
- •Use of atorvastatin , alprazolam , amlodipine , MTX , hydroxychloroquine by the patient
- •Lack of Informed consent
研究者
相似试验
已完成
2 期
Effect of TOCILIZUMAB (ACTEMRA) on treatment of COVID-19COVID-19 disease.COVID-19, virus not identifiedU07.2IRCT20081027001411N4Tehran University of Medical Sciences40
招募中
3 期
Evaluation of The effect of tocilizumab on patients with severe Covid 19IRCT20210408050899N1Ahvaz University of Medical Sciences15
已完成
2 期
A comparative study of the effects of Tocilizumab?, interferon-gamma and vitamin C on the recovery of critically ill Covid-19 patients and cytokine stormCovid-19.Covid-19 diseaseU07.1IRCT20200525047570N1Tabriz University of Medical Sciences60
招募中
2 期
Evaluation of the Effects of Tocilizumab Administration in Hospitalized COVID-19 PatientsIRCT20151227025726N29Iran University of Medical Sciences50
已完成
不适用
A Single-arm, Open-label Study of the Safety and Reduction of Signs and Symptoms During Treatment With Tocilizumab in Combination With Methotrexate, in Patients With Moderate to Severe Active Rheumatoid Arthritis-M05M05PER-129-08PRODUCTOS ROCHE Q.F.S.A.,20